FactRight publishes due-diligence reports on Cypress Exchange Properties and new DST offering

Cypress Exchange Properties said FactRight has completed and posted independent due-diligence reports on the sponsor and its CXP Orthopedic Surgery Center DST. The reports are available to eligible financial professionals and add a third-party review layer for advisers evaluating the 1031-exchange-oriented offering.

Why it matters: - The FactRight reports give advisers and other eligible financial professionals an independent review of Cypress Exchange Properties and the CXP Orthopedic Surgery Center DST. - The publication may help investors and advisers assess a Rule 506(c) offering tied to a possible Section 1031 tax-deferred exchange. - The reports are available through the FactRight Report Center and FactRight Report Center.

What happened: - Cypress Exchange Properties said FactRight completed and published due-diligence reports covering Cypress Exchange Properties as a sponsor and the CXP Orthopedic Surgery Center DST. - The announcement was made Aug. 18, 2026. - The reports are available for eligible financial professionals to access and download.

The details: - The CXP Orthopedic Surgery Center DST is a Rule 506(c) offering with a $50,000 minimum investment. - The offering is structured for accredited investors, including investors seeking to complete a tax-deferred exchange under Section 1031 of the Internal Revenue Code. - Securities tied to the offering are being offered through Emerson Equity LLC, which is a FINRA/SIPC member and is not affiliated with Cypress Exchange Properties. - FactRight provides independent due-diligence and risk-management services for the alternative-investment industry. - FactRight serves registered investment advisers, broker-dealers, family offices and other wealth-management professionals evaluating alternative-investment sponsors and offerings. - FactRight’s sponsor review covers management team, organizational structure, operating history, financial condition, internal controls and operational capabilities. - FactRight’s offering-level analysis examines the investment structure, underlying real estate, financing, fees, assumptions, potential risks and other material terms. - Christopher Cumella, president and CEO of Cypress Exchange Properties, said the company was pleased to complete FactRight’s review process and make the reports available to financial professionals. - Cumella said transparency, disciplined underwriting and strong operating practices are central to the business. - Cumella said the reports provide advisers and their due-diligence teams with an independent resource for evaluating the company and the offering. - Eligible financial professionals can log into the FactRight Report Center and search for Cypress Exchange Properties or CXP Orthopedic Surgery Center DST. - Additional offering information is available at cypressxp.com. - Interested investors and financial professionals may also contact the company at info@cypressxp.com.

Between the lines: - Third-party due-diligence reports can make a private real estate offering easier for advisers to review and compare against other options. - The disclosure that the report is not an endorsement or investment recommendation is meant to keep the FactRight publication in a research role, not a sales role. - The structure also reinforces the separation between Cypress Exchange Properties and the brokerage firm distributing the securities.

What's next: - Eligible advisers can now use the reports as part of their screening and diligence process. - Cypress Exchange Properties is likely to continue marketing the DST through the private placement documents and its distribution channels. - Investors still face the usual risks tied to private real estate offerings, including possible loss of principal. - The company’s disclosures say any offering is made only through the applicable private placement memorandum and related documents.